C156H162F3N23O5 — CID 161036459
2-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-4-carboxamide;5-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;5-[(5-methyl-4-phenylpyrimidin-2-yl)methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;2-[6-methyl-5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]-1-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]ethanone;1-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-2-[5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]ethanone (PubChem CID 161036459) has the molecular formula C156H162F3N23O5 and a molecular weight of 2496.16 g/mol. Its IUPAC name is 2-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-4-carboxamide;5-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;5-[(5-methyl-4-phenylpyrimidin-2-yl)methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;2-[6-methyl-5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]-1-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]ethanone;1-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-2-[5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]ethanone.
| Compound Name | 2-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-4-carboxamide;5-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;5-[(5-methyl-4-phenylpyrimidin-2-yl)methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;2-[6-methyl-5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]-1-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]ethanone;1-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-2-[5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]ethanone |
|---|---|
| PubChem CID | 161036459 |
| Molecular Formula | C156H162F3N23O5 |
| Molecular Weight | 2496.16 g/mol |
| Exact Mass | 2494.31 |
| IUPAC Name | 2-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-4-carboxamide;5-[[4-(3-methylphenyl)pyrimidin-2-yl]methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;5-[(5-methyl-4-phenylpyrimidin-2-yl)methyl]-N-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]pyridine-3-carboxamide;2-[6-methyl-5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]-1-[4-(piperidin-1-ylmethyl)-3-(trifluoromethyl)phenyl]ethanone;1-[4-[(4-methylpiperidin-1-yl)methyl]phenyl]-2-[5-[(4-phenylpyrimidin-2-yl)methyl]-3-pyridinyl]ethanone |
| SMILES | CC1CCN(Cc2ccc(C(=O)Cc3cncc(Cc4nccc(-c5ccccc5)n4)c3)cc2)CC1.Cc1cccc(-c2ccnc(Cc3cc(C(=O)Nc4ccc(CN5CCC(C)CC5)cc4)ccn3)n2)c1.Cc1cccc(-c2ccnc(Cc3cncc(C(=O)Nc4ccc(CN5CCC(C)CC5)cc4)c3)n2)c1.Cc1cnc(Cc2cncc(C(=O)Nc3ccc(CN4CCC(C)CC4)cc3)c2)nc1-c1ccccc1.Cc1ncc(CC(=O)c2ccc(CN3CCCCC3)c(C(F)(F)F)c2)cc1Cc1nccc(-c2ccccc2)n1 |
| InChI | InChI=1S/C32H31F3N4O.3C31H33N5O.C31H32N4O/c1-22-27(19-31-36-13-12-29(38-31)24-8-4-2-5-9-24)16-23(20-37-22)17-30(40)25-10-11-26(28(18-25)32(33,34)35)21-39-14-6-3-7-15-39;1-22-12-16-36(17-13-22)21-24-6-8-27(9-7-24)34-31(37)26-10-14-32-28(19-26)20-30-33-15-11-29(35-30)25-5-3-4-23(2)18-25;1-22-11-14-36(15-12-22)21-24-6-8-28(9-7-24)34-31(37)27-17-25(19-32-20-27)18-30-33-13-10-29(35-30)26-5-3-4-23(2)16-26;1-22-12-14-36(15-13-22)21-24-8-10-28(11-9-24)34-31(37)27-16-25(19-32-20-27)17-29-33-18-23(2)30(35-29)26-6-4-3-5-7-26;1-23-12-15-35(16-13-23)22-24-7-9-28(10-8-24)30(36)18-25-17-26(21-32-20-25)19-31-33-14-11-29(34-31)27-5-3-2-4-6-27/h2,4-5,8-13,16,18,20H,3,6-7,14-15,17,19,21H2,1H3;3-11,14-15,18-19,22H,12-13,16-17,20-21H2,1-2H3,(H,34,37);3-10,13,16-17,19-20,22H,11-12,14-15,18,21H2,1-2H3,(H,34,37);3-11,16,18-20,22H,12-15,17,21H2,1-2H3,(H,34,37);2-11,14,17,20-21,23H,12-13,15-16,18-19,22H2,1H3 |
| InChIKey | UAHVDYPAXXAMIN-UHFFFAOYSA-N |
| XLogP | 30.42 |
| TPSA | 330.99 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 187 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2496.16 |
| LogP ≤ 5 | 30.42 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 25 |